Dr. Bazhenova on Sequential Use of Immunotherapy and EGFR TKIs in Lung Cancer
June 11th 2019Lyudmila A. Bazhenova, MD, medical oncologist, professor of clinical medicine, University of California, San Diego, discusses research that has looked at the use of EGFR TKIs after immunotherapy in patients with EGFR-mutant non–small cell lung cancer.
Read More
Dr. Bazhenova on Sequencing Beyond Progression in EGFR-Mutant NSCLC
May 30th 2019Lyudmila A. Bazhenova, MD, medical oncologist, professor of clinical medicine, University of California, San Diego, discusses sequencing beyond progression on osimertinib (Tagrisso) in EGFR-mutant non–small cell lung cancer (NSCLC).
Read More